Peripheral Atherosclerotic Disease
2 clinical trials · Condition
◉ Watch Peripheral Atherosclerotic Disease
| Record | Firm | Date |
|---|---|---|
| PAtients With Symptomatic Peripheral Artery Disease on Rivaroxaban-acetylsalicylic Acid Combination Therapy (PRO-PAS) (NCT06239415) | Istituti Clinici Scientifici Maugeri SpA | 2022-03-31 |
Track Peripheral Atherosclerotic Disease automatically
Every clearance here is in the API, with alerts when new ones post.